183 related articles for article (PubMed ID: 36276151)
21. Case Report: Transarterial Chemoembolization in Combination With Tislelizumab Downstages Unresectable Hepatocellular Carcinoma Followed by Radical Salvage Resection.
Chao J; Zhu Q; Chen D; An X; Liu A; Zhou F; Yuan L; Wang Z; Sun H
Front Oncol; 2021; 11():667555. PubMed ID: 33869071
[TBL] [Abstract][Full Text] [Related]
22. Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report.
Chen Z; Chen Z; Fan W; Zou Y; Zhang Y; Shi N; Jin H
World J Surg Oncol; 2023 Jan; 21(1):29. PubMed ID: 36721173
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma.
Ren Y; Guo Y; Chen L; Sun T; Zhang W; Sun B; Zhu L; Xiong F; Zheng C
Cancer Control; 2022; 29():10732748221076806. PubMed ID: 35343254
[TBL] [Abstract][Full Text] [Related]
25. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
[TBL] [Abstract][Full Text] [Related]
26. Safety and Efficacy of Transarterial Chemoembolization and Immune Checkpoint Inhibition with Camrelizumab for Treatment of Unresectable Hepatocellular Carcinoma.
Zhang JX; Chen P; Liu S; Zu QQ; Shi HB; Zhou CG
J Hepatocell Carcinoma; 2022; 9():265-272. PubMed ID: 35388358
[TBL] [Abstract][Full Text] [Related]
27. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
[TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
[TBL] [Abstract][Full Text] [Related]
29. Effect of resection following downstaging of unresectable hepatocelluar carcinoma by transcatheter arterial chemoembolization.
Shi XJ; Jin X; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
Chin Med J (Engl); 2012 Jan; 125(2):197-202. PubMed ID: 22340545
[TBL] [Abstract][Full Text] [Related]
30. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
[TBL] [Abstract][Full Text] [Related]
31. Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy.
Hatanaka T; Yata Y; Naganuma A; Kakizaki S
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980684
[TBL] [Abstract][Full Text] [Related]
32. Safety and Survival Outcomes of Liver Resection following Triple Combination Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma.
Long Y; Huang J; Liao J; Zhang D; Huang Z; He X; Zhang L
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136422
[TBL] [Abstract][Full Text] [Related]
33. Preservation of segment 4 inferior by distal middle hepatic vein reconstruction combined with extended right hepatectomy after portal vein embolization in a patient with a huge initially unresectable HCC.
Nakano H; Kikuchi K; Seta S; Katayama M; Yamamura T; Otsubo T
Hepatogastroenterology; 2007; 54(77):1563-6. PubMed ID: 17708300
[TBL] [Abstract][Full Text] [Related]
34. Two hepatectomy cases for initially unresectable hepatocellular carcinoma after achieving a radiological complete response to sequential therapy with lenvatinib and transcatheter arterial chemoembolization.
Endo K; Kuroda H; Abe T; Sato H; Kooka Y; Oikawa T; Sato A; Nishiya M; Sugai T; Takikawa Y
Hepatol Res; 2021 Oct; 51(10):1082-1086. PubMed ID: 33982336
[TBL] [Abstract][Full Text] [Related]
35. Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature.
Chu JH; Huang LY; Wang YR; Li J; Han SL; Xi H; Gao WX; Cui YY; Qian MP
World J Gastrointest Oncol; 2024 Apr; 16(4):1647-1659. PubMed ID: 38660668
[TBL] [Abstract][Full Text] [Related]
36. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
Trials; 2012 Aug; 13():144. PubMed ID: 22913492
[TBL] [Abstract][Full Text] [Related]
37. Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with multiple tumor thrombi and pulmonary metastases: A case report.
Huang DJ; Li YH; Luo YC; Huang JZ; He HY
Oncol Lett; 2016 Sep; 12(3):2103-2106. PubMed ID: 27602147
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study.
Chen R; Li L; Li Y; Song K; Shen C; Ma P; Wang Z
J Gastrointest Oncol; 2022 Jun; 13(3):1367-1375. PubMed ID: 35837188
[TBL] [Abstract][Full Text] [Related]
39. Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma.
Lopez RR; Pan SH; Hoffman AL; Ramirez C; Rojter SE; Ramos H; McMonigle M; Lois J
Arch Surg; 2002 Jun; 137(6):653-7; discussion 657-8. PubMed ID: 12049535
[TBL] [Abstract][Full Text] [Related]
40. Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis.
Si T; Huang Z; Khorsandi SE; Ma Y; Heaton N
Front Bioeng Biotechnol; 2022; 10():1010824. PubMed ID: 36237208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
